PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 79 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $13,000 | -91.7% | 20,834 | -91.3% | 0.00% | -100.0% |
| Q1 2017 | $156,000 | +2128.6% | 238,906 | +941.5% | 0.00% | – |
| Q4 2016 | $7,000 | -70.8% | 22,939 | -58.8% | 0.00% | -100.0% |
| Q3 2016 | $24,000 | 0.0% | 55,728 | -14.0% | 0.00% | – |
| Q2 2016 | $24,000 | -70.4% | 64,786 | -6.0% | 0.00% | -100.0% |
| Q4 2015 | $81,000 | -15.6% | 68,901 | -6.4% | 0.00% | -50.0% |
| Q2 2015 | $96,000 | +336.4% | 73,585 | +356.7% | 0.00% | – |
| Q1 2015 | $22,000 | -62.7% | 16,112 | -62.0% | 0.00% | -100.0% |
| Q4 2014 | $59,000 | -49.1% | 42,360 | -50.3% | 0.00% | -50.0% |
| Q3 2014 | $116,000 | +123.1% | 85,152 | +208.7% | 0.00% | +100.0% |
| Q2 2014 | $52,000 | -61.8% | 27,581 | -61.8% | 0.00% | -50.0% |
| Q1 2014 | $136,000 | +7.1% | 72,162 | -21.2% | 0.00% | +100.0% |
| Q4 2013 | $127,000 | +39.6% | 91,568 | +40.1% | 0.00% | 0.0% |
| Q3 2013 | $91,000 | – | 65,349 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tappan Street Partners LLC | 11,593,530 | $7,049,000 | 20.61% |
| Bandera Partners LLC | 1,421,000 | $864,000 | 0.78% |
| Brown Advisory Securities, LLC | 580,000 | $353,000 | 0.08% |
| Sterling Global Strategies LLC | 20,000 | $12,000 | 0.06% |
| Freedom Investment Management, Inc. | 1,052,770 | $642,000 | 0.04% |
| BAXTER BROS INC | 150,500 | $92,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 576,897 | $351,000 | 0.01% |
| Ballentine Partners, LLC | 25,001 | $113,000 | 0.01% |
| LEVEL FOUR ADVISORY SERVICES, LLC | 57,700 | $37,000 | 0.01% |
| Spark Investment Management LLC | 128,600 | $78,000 | 0.01% |